Company Filing History:
Years Active: 2018
Title: The Innovative Mind of Po-Hao Lin in Hematocrit Measurement
Introduction
Po-Hao Lin, an inventor based in Zhongli, Taiwan, has made significant contributions to the field of medical diagnostics with his innovative approach to measuring hematocrit (HCT). His work focuses on creating reliable and precise methods for blood measurement, which are essential in various medical applications.
Latest Patents
Po-Hao Lin holds a patent for a novel "Method of Measuring Hematocrit (HCT) and Measurement Device Using the Method." This invention utilizes a unique technique that involves instilling blood into a pair of test electrodes and applying voltage to measure hematocrit through capacitor charging effects and changes in discharge current. The key steps involve measuring the discharge current after voltage removal, applying a predetermined decision rule, and ultimately obtaining a hematocrit value for blood. This advanced method enhances both precision and reliability compared to traditional hematocrit testing methods.
Career Highlights
Lin currently works at Broadmaster Biotech Corp., where he brings his innovative ideas to life in the medical device sector. His commitment to improving blood measurement techniques showcases his dedication to advancing healthcare technology. The impact of his work is profound, as accurate hematocrit measurement is crucial in diagnosing and monitoring various health conditions.
Collaborations
Throughout his career, Po-Hao Lin has collaborated with talented individuals, including Yi-Lung Chen and Chien-Hung Lai. These partnerships have allowed for the exchange of ideas and skills that further enhance the innovation process, resulting in effective solutions for the medical community.
Conclusion
Po-Hao Lin is a prominent inventor whose work in hematocrit measurement has made significant strides in medical diagnostics. His patent exemplifies the intersection of technology and healthcare, promising to improve patient outcomes. As he continues to innovate at Broadmaster Biotech Corp., the medical field looks forward to the advancements that his contributions will undoubtedly bring.